Triple-negative breast cancer (TNBC) comprises 10 % to 20 % of breast cancers and is characterized by a lack of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor-2 (HER2) expression. This evidence concerns the gene PGR and breast cancer.